Vlatko Pejša

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat et al. · New England Journal of Medicine · 2020 · 2.8K citations · Full text

Medicine, Pharmacotherapy, Medical Oncology +3

Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis

Marko Lucijanić, Ivo Veletić, Dario Rahelić et al. · Wiener klinische Wochenschrift · 2018 · 38 citations · Full text

Medicine, Clinical Sciences, Hematology +13

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

Keith W. Pratz, Panayiotis Panayiotidis, Christian Récher et al. · Blood Cancer Journal · 2022 · 35 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Elevated Neutrophil–to–Lymphocyte-ratio and Platelet–to–Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself?

Marko Lucijanić, David Čičić, Tajana Štoos‐Veić et al. · Anticancer Research · 2018 · 34 citations · Full text

Medicine, Hematology, Pathology +17

The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis

Marko Lucijanić, Vlatko Pejša, Ozren Jakšić et al. · Acta Haematologica · 2016 · 25 citations

Medicine, Hematology, Pathology +17